HOME >> MEDICINE >> NEWS
Other highlights in the May 2 JNCI

Study Confirms Tamoxifen Prevents Breast Cancer in High-Risk Women

Women at high risk for breast cancer who have undergone a hysterectomy appear to benefit from taking tamoxifen to prevent breast cancer, according to an extended follow-up of the Italian Randomized Tamoxifen Trial.

The initial findings from the Italian trial showed no significant reduction in breast cancer risk with tamoxifen use. However, the National Surgical Adjuvant Breast and Bowel Projects Breast Cancer Prevention Trial found that tamoxifen reduced the risk of estrogen receptor-positive breast cancer.

Umberto Veronesi, M.D., of the European Institute of Oncology in Milan, and colleagues randomly assigned 5,408 healthy women who had a hysterectomy to receive tamoxifen or a placebo for five years.

After 11 years of follow-up, 136 women developed breast cancer74 in the placebo group and 62 in the tamoxifen group. Among low-risk women, rates of breast cancer were similar in the tamoxifen and placebo groups. But for women at high risk, breast cancer rates were lower for those taking tamoxifen. Women taking tamoxifen experienced more side effects, including hot flashes and heart problems, than women in the placebo group.

"A complete assessment of the baseline cardiovascular risk should become an important component of counseling women on the use of tamoxifen, particularly in the prevention setting," the authors write.

Contact: Donata Francese, European Institute of Oncology, dfrancese@consulenti-associati.it, +39 02 89 075034


Drug Combination Halts Tumor Growth Better Than Single Agent

Treatment with three drugs that inhibit the human epidermal growth factor receptor (HER) stops HER2-positive breast cancer tumor growth in mice better than treatment with just one or two of the drugs.

Grazia Arpino, M.D., Ph.D., of Baylor Colleg
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
1-May-2007


Page: 1 2 3 4

Related medicine news :

1. Other highlights in the Dec. 6 JNCI
2. Other illnesses play role in difference in breast cancer survival rates between blacks and whites
3. Other highlights in the October 5 JNCI
4. Other highlights in the July 20 JNCI
5. Other highlights in the May 18 JNCI
6. Other highlights in the May 4 JNCI
7. Research highlights from Thoracic Society Conference
8. SCAI highlights study using wireless technology to speed care of heart attack patients
9. SCAI Founders Lecture highlights remarkable progress in catheter-based aortic valve replacement
10. Latest IPCC report highlights need for integrated climate/human behavior models
11. New report highlights aromatase inhibitor side effects

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... , ... “Fruit of the Spirit: “Love””: a delightful adventure of two ... “Fruit of the Spirit: “Love”” is the creation of published author, Halimah Jones, who ... five. Halimah is an avid writer, her inspiration for “Fruit of the Spirit: “Love”” ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... preserve fertility and create life. Although frozen embryos have a slight statistical advantage ... , “Egg freezing is a wonderful opportunity for women undergoing medical treatment or ...
(Date:9/21/2017)... FL (PRWEB) , ... September 21, 2017 , ... 38-Year-Old ... Aesthetic Surgery Center in Naples, Florida is pleased to announce that Plastic Surgeon Kiranjeet ... Top 40 Under 40 is an annual award that was started in ...
(Date:9/21/2017)... CA (PRWEB) , ... September 21, 2017 , ... ... lunch and learn with Infinity Behavioral Health Services for professionals in the addiction ... a Commercial Payer Audit . , Insurance companies and state and federal ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... communities, nine governmental public health departments have been awarded five-year accreditation status through ... that the benefits of being served by a PHAB-accredited health department now ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017 NuvoAir (formerly called Pond Healthcare ... a partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry ... the leading mobile spirometry platform and Novartis, commitment to address ... ... ...
(Date:9/6/2017)... TORONTO , Sept. 6, 2017 /PRNewswire/ ... new knowledge and skills while treating their ... for hands-on experience without involving patients. Simulation ... skills. Clinicians can carry out procedures, refine ... at risk. Integration of new technology, such ...
(Date:9/5/2017)... , Sept. 5, 2017 Sapheneia and ... DoseCheck solution. Scannerside DoseCheck is a third-party Vendor neutral ... CT scanners and allows compliance with current MITA standards. ... proprietary XR 29 DoseCheck solution is specifically designed to ... alerts of potential radiation doses over a predefined threshold. ...
Breaking Medicine Technology:
Cached News: